Sign In
Buy RDY
$13.02
-0.0100 (-0.0767%)
At Close: Jun 03, 2026
NYSE Content Update: Dell Technologies Reports 88% Revenue Increase YoY
08:55am, Friday, 29'th May 2026
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, May 29, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NY
Dr. Reddy's Launches Generic Semaglutide In Canada, Expands GLP-1 Push
03:17pm, Saturday, 16'th May 2026
Dr. Reddy's launched generic Semaglutide Injection in Canada, expanding its GLP-1 portfolio and strengthening its affordable diabetes treatment presence.
Dr. Reddy's Laboratories Launches its Generic Semaglutide Injection in Canada
03:18am, Saturday, 16'th May 2026
HYDERABAD, India & MISSISSAUGA, Ontario--(BUSINESS WIRE)---- $RDY #DrReddy--Dr. Reddy's Laboratories Ltd. a global pharmaceutical company, today announced the launch of its generic Semaglutide Injecti
Dr. Reddy's Laboratories Q4 Earnings Call Highlights
08:12am, Thursday, 14'th May 2026
Dr. Reddy's Laboratories NYSE: RDY reported what Chief Financial Officer M.V. Narasimham described as a resilient FY 2026 performance, with record annual revenue despite pressure from lower lenalidomi
Dr. Reddy's Q4 Earnings and Revenues Miss Estimates, Stock Down
12:25pm, Wednesday, 13'th May 2026
RDY stock down 5% on missing fiscal fourth-quarter 2026 earnings and revenue estimates as North America generics sales slumped.
Dr. Reddy's Laboratories Limited (RDY) Q4 2026 Earnings Call Transcript
02:50pm, Tuesday, 12'th May 2026
Dr. Reddy's Laboratories Limited (RDY) Q4 2026 Earnings Call Transcript
Indian drugmaker Dr Reddy's posts quarterly profit slump
07:16am, Tuesday, 12'th May 2026
Indian drugmaker Dr Reddy's reported an 86% slump in quarterly profit on Tuesday, hurt by pricing pressure and increasing competition in its key U.S. market.
AMPH vs. RDY: Which Stock Should Value Investors Buy Now?
12:41pm, Wednesday, 29'th Apr 2026
Investors interested in stocks from the Medical - Generic Drugs sector have probably already heard of Amphastar Pharmaceuticals (AMPH) and Doctor Reddy's (RDY). But which of these two companies is the
Canada Approves Dr. Reddy's Generic Version of Novo Nordisk's Ozempic
12:37pm, Wednesday, 29'th Apr 2026
The country is the first in the G7 forum to approve a generic version of the massively popular GLP-1 diabetes treatment.
Dr. Reddy's Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in Canada
07:38am, Wednesday, 29'th Apr 2026
HYDERABAD, India & MISSISSAUGA, Ontario--(BUSINESS WIRE)---- $RDY #DrReddy--Dr. Reddy's Laboratories Ltd. announced that it has received a Notice of Compliance (NOC) from Health Canada for its generic
India's Generic Wave Hits Ozempic And Wegovy As Prices Drop Sharply
09:00am, Monday, 23'rd Mar 2026
India's drugmakers roll out low-cost copies for Novo Nordisk's semaglutide, slashing prices up to 70% as analysts weigh global market disruption risks.
3 Generic Drug Stocks to Watch Despite Industry Headwinds
10:45am, Wednesday, 04'th Mar 2026
Generic drugmakers face pricing pressure, but companies like TEVA, SDZNY and RDY are betting on complex generics and biosimilars to protect growth.
HYDERABAD, India--(BUSINESS WIRE)---- $RDY #Abatacept--Dr. Reddy's announces USFDA acceptance to review its Biologics License Application (BLA) for proposed interchangeable biosimilar, Abatacept.
Dr. Reddy’s Laboratories Ltd $RDY Shares Acquired by Bessemer Group Inc.
04:40am, Saturday, 07'th Feb 2026
Bessemer Group Inc. raised its holdings in shares of Dr. Reddy's Laboratories Ltd (NYSE: RDY) by 30.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchan
Dr. Reddy’s Laboratories Q3 Earnings Call Highlights
01:02am, Friday, 23'rd Jan 2026
Dr. Reddy's Laboratories (NYSE: RDY) reported a "resilient performance" in its fiscal third quarter of FY26, with revenue growth and steady profitability despite what management described as product-s
